4D Molecular Therapeutics, Inc. (FDMT)

NASDAQ: FDMT · Real-Time Price · USD

9.77

+0.11 (1.14%)

At close: Apr 15, 2026, 4:00 PM EDT

9.46

-0.31 (-3.17%)

After-hours: Apr 15, 2026, 6:21 PM EDT

4D Molecular Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	60.24	149.34	249.11	52.35	153
Short-Term Investments	342.41	275.54	39.12	161.2	94.78
Cash & Short-Term Investments	402.66	424.88	288.23	213.55	247.78
Cash Growth	-5.23%	47.41%	34.97%	-13.81%	-10.46%
Accounts Receivable	-	-	-	-	0.05
Other Current Assets	10.48	10.06	8.36	6.96	8.46
Total Current Assets	413.13	434.93	296.59	220.51	256.28
Net Property, Plant & Equipment	33.01	40.61	31.67	35.35	28.95
Long-Term Investments	111.38	80.58	10.95	4.91	67.65
Other Long-Term Assets	9.19	4.26	0.68	1.08	0.6
Total Assets	566.71	560.38	339.89	261.85	353.49
Accounts Payable	11.16	4.39	3.52	3.32	4.76
Accrued Expenses	26.87	18.87	12.01	8.87	7.74
Current Portion of Leases	5.59	5.64	3.15	2.66	1.23
Unearned Revenue	0.36	0.26	0.27	0.88	2.6
Total Current Liabilities	43.99	29.15	18.95	15.73	16.34
Long-Term Leases	15.82	18.97	11.52	13.47	15.22
Other Long-Term Liabilities	1.24	1.66	1.59	1.31	2.83
Total Long-Term Liabilities	17.06	20.63	13.11	14.78	18.04
Total Liabilities	61.05	49.78	32.06	30.51	34.38
Common Stock	0.01	0.01	0	0	0
Additional Paid-in Capital	1,221	1,087	723.14	547.02	526.52
Accumulated Other Comprehensive Income	0.73	0.23	0.02	-1.2	-0.42
Retained Earnings	-716.3	-576.2	-415.33	-314.49	-207
Shareholders' Equity	505.66	510.61	307.83	231.34	319.11
Total Liabilities & Equity	566.71	560.38	339.89	261.85	353.49
Total Debt	21.41	24.61	14.67	16.12	16.45
Net Cash (Debt)	381.24	400.27	273.56	197.43	231.33
Net Cash Growth	-4.75%	46.32%	38.56%	-14.65%	-16.41%
Net Cash Per Share	6.58	7.42	6.99	6.10	8.34
Book Value	505.66	510.61	307.83	231.34	319.11
Book Value Per Share	8.73	9.47	7.87	7.15	11.51
Tangible Book Value	505.66	510.61	307.83	231.34	319.11
Tangible Book Value Per Share	8.73	9.47	7.87	7.15	11.51

Updated Mar 18, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q